Dennis Douda (@ddouda)
Activity by Dennis Douda
In the United States, two-thirds of the population is said to be either overweight or obese. Now there’s a new option for those who might need medical help to lose weight but don’t qualify for weight loss surgery.
This week Mayo Clinic gastroenterologists were the first in the U.S. to implant a new device recently approved by the FDA. The procedure involves the temporary placement of a special balloon in the stomach and has the potential for lasting results. Here’s Dennis Douda for the Mayo Clinic News Network.
Journalists: A broadcast quality video package is available in the downloads. Click here to read the full script. Sound bites with Dr. Acosta areac also available.
Mayo Clinic has a financial interest in Apollo Endosurgery, manufacturer of the ORBERA managed weight loss system. Revenue Mayo Clinic receives is used to support its not-for-profit mission in patient care, education and research.
The Trans Am Muscle Car Challenge promises to be a high-octane event Friday in Lexington, Ohio. But, one of the drivers is already a winner. With help from his extensive Mayo Clinic health care team, Tommy Archer outraced prostate cancer in order to get back on the track. Here’s Dennis Douda for the Mayo Clinic News Network.
Journalists: A broadcast quality video package is available in the downloads. Click here to read the full script.
On any given day about 15,000 Americans are on the liver transplant waiting list, hoping they can get a lifesaving donor organ in time. It’s that kind of statistic that’s had doctors looking for alternatives for decades. Now, a new study in the Journal of Hepatology reports that Mayo Clinic researchers may have a bioartificial liver ready to do the job for some of those patients. Here’s Dennis Douda for the Mayo Clinic News Network.
With Father’s Day coming up, everyone wants to give Dad something he can really use. So, how about a gift that might even save his life? That was the idea behind a Mayo Clinic nurse’s gift; a tourniquet, of all things! Here’s Dennis Douda for the Mayo Clinic News Network. [TRT 2:29]
Journalists, a broadcast quality package and a how-to video demonstrating proper tourniquet use are available in the downloads.
The FDA may approve the new medications for use later this year.
A Food and Drug Administration (FDA) advisory panel has recommended approval of the first drug in a new class of cholesterol-lowering medications, called PCSK9 inhibitors. PCSK9 is a protein that interferes with the liver's ability to reduce levels of LDL, often called the bad cholesterol. A similar drug made by another company will be considered by the panel today. "The thing that’s different about [these medications] is that they actually enhance your own body’s ability to clear cholesterol," says Stephen Kopecky, M.D., with Mayo Clinic's division of cardiovascular diseases and the immediate past president of the American Society for Preventive Cardiology (ASPC).
Mayo Clinic participated in some of the research to evaluate the medications. “Of the three that are coming along, we’ve studied two of them here, giving them to patients in research studies and looked at their benefits and side effects; their good effects and bad effects. We’ve found them to be very, very effective,” Dr. Kopecky says.
Play the video to hear more of Dr. Kopecky's comments about how the drugs work and why they could be lifesavers for some patients with high cholesterol.
Journalists, broadcast quality sound bites from Dr. Kopecky are available in the downloads. To read a transcript of his comments about which patients may benefit most and why working to lower cholesterol levels with lifestyle changes benefits more than just heart health, click here.
Full disclosure: Dr. Kopecky is an adviser to the pharmaceutical company Merck, which is not one of the companies awaiting FDA approval for a PCSK9 inhibitor medication.
"Children with food allergies and asthma have a higher risk of a severe allergic reaction to the food allergy, than does a child without asthma," says Mayo Clinic Children's Center, Martha Hartz, M.D., division chair of Pediatric Allergy and Immunology.
Dr. Hartz says, in general, children with asthma are more likely to be allergic to peanuts, as well as other foods. New research presented at the American Thoracic Society 2015 International Conference found that half of families whose children have asthma were unaware their child also had a peanut sensitivity. She says it's an issue to be taken seriously. "Peanut allergy is the most common cause of fatal food anaphylaxis in the country," Dr. Hartz says. "So, parents are appropriately concerned about peanut allergy."
Children with asthma who have shown a history of food allergy may benefit from allergy testing. However, she says, screening broadly across the population is likely to cause more problems than it solves, with too many false positive results. For those children with known peanut allergies, Dr. Hartz urges careful avoidance of any foods that may contain peanut products and to always carry an epinephrin injector pen in case of emergency. Click on the video to hear more of Dr. Hartz's advice, including how exposing children to peanut butter at a very young age may prevent peanut allergies.
To read more about the latest research linking asthma and peanut allergies, click here.
Journalists, broadcast quality sound bites from Dr. Hartz are available in the downloads. To read a transcript of her comments, click here.
Medical innovation has helped a Chicago-area woman receive a lifesaving double organ transplant, even after she’d been told it wasn’t an option. Previous surgeries had made her risk of organ rejection too high. Her Mayo Clinic doctors, however, turned her dire situation into an advantage. Here’s Dennis Douda with the Mayo Clinic News Network.
Courtney is working to raise organ donor awareness. Anyone who’d like to wish her well can do so at her Facebook page.
Journalists: The broadcast quality video package and additional b-roll are available in the downloads. Click here to read the full script.
Mayo Clinic will soon begin treating cancer patients with its new, state-of-the-art proton beam therapy facility. The technology delivers radiation therapy in a way that offers the potential for fewer side effects and higher cure rates, often for patients whose cancers cannot be treated safely any other way. Here’s Dennis Douda for the Mayo Clinic News Network.
Journalists: The broadcast quality video package, additional b-roll of the building and facility, as well as elaborate animations, are available in the downloads. Click here to read the full script.
Learn more about the Grand Opening Event Saturday May 9th, 11 am - 3 pm CT.